Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Shicheng Guo
Fengyang Yan
Jibin Xu
Yang Bao
Ji Zhu
Xiaotian Wang
Junjie Wu
Yi Li
Weilin Pu
Yan Liu
Zhengwen Jiang
Yanyun Ma
Xiaofeng Chen
Momiao Xiong
Li Jin
Jiucun Wang
机构：
[1] Collaborative Innovation Center for Genetics and Development,State Key Laboratory of Genetic Engineering and Ministry of Education Key Laboratory of Contemporary Anthropology
[2] School of Life Sciences and Institutes of Biomedical Sciences,Department of Cardiothoracic Surgery
[3] Fudan University Jiangwan Campus,Department of Cardiothoracic Surgery
[4] Changzheng Hospital of Shanghai,Department of Pneumology
[5] Yangzhou No.1 People’s Hospital,Center for Genetic & Genomic Analysis
[6] Changhai Hospital of Shanghai,Department of Cardiothoracic Surgery
[7] Changhai Hospital of Shanghai,Human Genetics Center
[8] Genesky Biotechnologies Inc.,undefined
[9] Huashan Hospital,undefined
[10] Fudan University,undefined
[11] The University of Texas School of Public Health,undefined
[12] Fudan-Taizhou Institute of Health Sciences,undefined
来源：
Clinical Epigenetics | 2015年 / 7卷
关键词：
Non-small cell lung cancer; DNA methylation; Biomarker; Batch effect elimination; Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [22] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [23] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [24] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [25] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [26] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [29] DNA Methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer
    Belinsky, Steven A.
    Schiller, Joan H.
    Stidley, Christine A.
    NUTRITION REVIEWS, 2008, 66 (08) : S24 - S26
  • [30] DNA methylation signatures as potential novel prognostic biomarkers in sub-types of Non-Small Cell Lung Cancer (NSCLC)
    Chwialkowska, K.
    Niemira, M.
    Bielska, A.
    Szalkowska, A.
    Kretowski, A.
    Niklinski, J.
    Kwasniewski, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1729 - 1729
12345